Loading
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Latest filing published 14 May 2025 for Keycorp /new/, €57k.
Filing timeline
BuySaleH. James Dallas
Insider track record
Disclosed buys
7
Disclosed sells
0
Signal history
Closed purchases
Market purchases
7
Positive at T+90
80%
Median T+90
+4.4%
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -34.1%Entry US$59.49 · Close at T+365 US$39.22
- -18.9%Entry US$82.91 · Close at T+365 US$67.22
- +35.8%Entry US$123.19 · Close at T+365 US$167.27
- -12.4%Entry US$21.14 · Close at T+365 US$18.51
- +65.2%Entry US$11.08 · Close at T+365 US$18.30
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
H. James Dallas: trading record in brief
H. James Dallas appears as a director of five US companies: Centene Corp (23 filings), Keycorp /new/ (23), Wellcare Health Plans, Inc. (7), Strategic Education, Inc. (6) and Capella Education Co (4). The record holds 63 filings published from January 27, 2016 to May 14, 2025, and no sale.
The 7 purchases total EUR 1.1 million, with a median of EUR 171,012. They are spread over Centene, Keycorp and Wellcare (2 each) and Strategic Education (1). The three largest are dated December 4, 2018 (EUR 263,465), April 29, 2022 (EUR 238,537) and August 2, 2018 (EUR 173,356).
The record adds 29 share grants, 15 option exercises and 12 filings of another kind. The peak is 2018 with 11 filings, followed by 10 in 2020; the year 2025 has only 3. No filing falls in the last twelve months.
Filings appear a median of 2 days after the trade. The count of trades by Dallas within 30 days of colleagues is 2, 2 and 1. All in the same direction. Colleagues in order: Christopher J. Coughlin (Centene Corp), Theodore R. Samuels II (Centene Corp) and Alexander M. Cutler (Keycorp /new/).
Companies and markets linked to H. James Dallas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations63 total
4,312 shares@ US$14.706.6% of flowCommon SharesSEC:0000091576-25-000063:1
3,579 shares0Common StockSEC:0001071739-25-000113:0
8,626 sharesCommon SharesSEC:0000091576-25-000063:0
1,693 shares@ US$59.0122.6% of flowCommon StockSEC:0001071739-24-000229:0
Canonical exit: 16 Mar 2025 (T+90)
2,916 shares0Common StockSEC:0001071739-24-000119:0
3,287 shares@ US$14.865.2% of flowCommon SharesSEC:0000091576-24-000081:1
6,573 sharesCommon SharesSEC:0000091576-24-000081:0
6,938 shares@ US$10.677.9% of flowCommon SharesSEC:0000091576-23-000088:1
13,876 sharesCommon SharesSEC:0000091576-23-000088:0
2,947 shares0Common StockSEC:0001071739-23-000138:0
528.243 shares0Common StockSEC:0001071739-23-000104:0
459.109 shares0Common StockSEC:0001071739-23-000013:0
419.604 shares0Common StockSEC:0001071739-22-000347:0
451.481 shares0Common StockSEC:0001071739-22-000270:0
4,463 shares@ US$19.819.5% of flowCommon SharesSEC:0000091576-22-000084:1
8,928 sharesCommon SharesSEC:0000091576-22-000084:0
3,065 shares@ US$81.7556.7% of flowCommon StockSEC:0001071739-22-000218:0
Canonical exit: 28 Jul 2022 (T+90)
2,323 shares0Common StockSEC:0001071739-22-000200:0
457.206 shares@ US$82.028.0% of flowCommon StockSEC:0001071739-22-000141:0
426.505 shares0Common StockSEC:0001071739-22-000010:0
467.674 shares@ US$66.826.4% of flowCommon StockSEC:0001071739-21-000209:0
456.138 shares@ US$68.516.3% of flowCommon StockSEC:0001071739-21-000168:0
3,361 shares@ US$20.949.4% of flowCommon SharesSEC:0000091576-21-000073:1
6,723 sharesCommon SharesSEC:0000091576-21-000073:0
1,468 shares0Common StockSEC:0001179110-21-004690:0
25 of 63 declarations
